Breast Cancer Drugs: The Focus of Generics Manufacturers
GLOBOCAN estimates predict a substantive increase to 19.3 Million new cancer cases per year by 2025, due to growth and ageing of the global population. According to the National Cancer Institute's estimates, nearly 232,340 women would be diagnosed with and 39,620 women would die of breast cancer in 2013. The 5 year survival rate for a stage IV breast cancer patient is only 22%. Breast cancer is now the most common cancer both in developed and developing regions. The occurrence...
View full press release